Plate-Based Diversity Selection Based on Empirical HTS Data to Enhance the Number of Hits and Their Chemical Diversity

Abstract

Typically, screening collections of pharmaceutical companies contain more than a million compounds today. However, for certain high-throughput screening (HTS) campaigns, constraints posed by the assay throughput and/or the reagent costs make it impractical to screen the entire deck. Therefore, it is desirable to effectively screen subsets of the collection based on a hypothesis or a diversity selection. How to select compound subsets is a subject of ongoing debate. The authors present an approach based on extended connectivity fingerprints to carry out diversity selection on a per plate basis (instead of a per compound basis). HTS data from 35 Novartis screens spanning 5 target classes were investigated to assess the performance of this approach. The analysis shows that selecting a fingerprint-diverse subset of 250K compounds, representing 20% of the screening deck, would have achieved significantly higher hit rates for 86% of the screens. This measure also outperforms the Murcko scaffold-based plate selection described previously, where only 49% of the screens showed similar improvements. Strikingly, the 2-fold improvement in average hit rates observed for 3 of 5 target classes in the data set indicates a target bias of the plate (and thus compound) selection method. Even though the diverse subset selection lacks any target hypothesis, its application shows significantly better results for some targets—namely, G-protein-coupled receptors, proteases, and protein-protein interactions—but not for kinase and pathway screens. The synthetic origin of the compounds in the diverse subset appears to influence the screening hit rates. Natural products were the most diverse compound class, with significantly higher hit rates compared to the compounds from the traditional synthetic and combinatorial libraries. These results offer empirical guidelines for plate-based diversity selection to enhance hit rates, based on target class and the library type being screened. (Journal of Biomolecular Screening 2009:690-699)

Keywords

chemical diversity ECFP-6 descriptors hit rate Murcko scaffolds plate-based diversity selection screening library selection

References

Battersby BJ , Trau M. : Novel miniaturized systems in high-throughput screening. Trends Biotechnol 2002;20:167-173.

Davies JW , Glick M. , Jenkins JL : Streamlining lead discovery by aligning in silico and high-throughput screening . Curr Opin Chem Biol 2006;10:343-351.

Valler MJ , Green D. : Diversity screening versus focussed screening in drug discovery. Drug Discov Today 2000;5:286-293.

Parker CN : McMaster University data-mining and docking competition: computational models on the catwalk. J Biomol Screen 2005 ;10:647-648.

Parker CN , Shamu CE , Kraybill B. , Austin CP , Bajorath J. : Measure, mine, model, and manipulate: the future for HTS and chemoinformatics? Drug Discov Today 2006;11:863-865.

Schopfer U. , Engeloch C. , Stanek J. , Girod M. , Schuffenhauer A. , Jacoby E. , et al: The Novartis compound archive: from concept to reality. Comb Chem High Throughput Screen 2005;8:513-519.

Martin YC : Diverse viewpoints on computational aspects of molecular diversity . J Comb Chem 2001;3:231-250.

Roth HJ : There is no such thing as `diversity'! Curr Opin Chem Biol 2005;9:293-295.

Schuffenhauer A. , Brown N. , Selzer P. , Ertl P. , Jacoby E. : Relationships between molecular complexity, biological activity, and structural diversity . J Chem Inf Model 2006;46:525-535.

10.

Bemis GW , Murcko MA : The properties of known drugs: 1. Molecular frameworks. J Med Chem 1996;39:2887-2893.

11.

Hert J. , Willett P. , Wilton DJ , Acklin P. , Azzaoui K. , Jacoby E. , et al: Comparison of fingerprint-based methods for virtual screening using multiple bioactive reference structures. J Chem Inf Comput Sci 2004;44: 1177-1185.

12.

Bender A. , Glen RC : Molecular similarity: a key technique in molecular informatics. Org Biomol Chem 2004;2:3204-3218.

13.

Crisman TJ , Jenkins JL , Parker CN , Hill WA , Bender A. , Deng Z. , et al: "Plate cherry picking": a novel semi-sequential screening paradigm for cheaper, faster, information-rich compound selection. J Biomol Screen 2007;12:320-327.

14.

Rogers D. , Brown RD , Hahn M. : Using extended-connectivity fingerprints with Laplacian-modified Bayesian analysis in high-throughput screening follow-up. J Biomol Screen 2005;10:682-686.

15.

Glick M. , Jenkins JL , Nettles JH , Hitchings H. , Davies JW : Enrichment of high-throughput screening data with increasing levels of noise using support vector machines, recursive partitioning, and Laplacian-modified naive Bayesian classifiers. J Chem Inf Model 2006;46:193-200.

16.

Hert J. , Willett P. , Wilton DJ , Acklin P. , Azzaoui K. , Jacoby E. , et al: Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. Org Biomol Chem 2004;2:3256-3266.

17.

Glen RC , Bender A. , Arnby CH , Carlsson L. , Boyer S. , Smith J. : Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME. Idrugs 2006 ;9:199-204.

18.

Beckwith R. , Hoegenauer K. , Jenkins JL , Lehr P. , Ullrich T. , Weigand K. : Use of fused imidazole derivatives to mediate CCR3 related conditions . World Patent WO/2007/025751, March 8, 2007.

19.

Breitenstein W. , Ehrhardt C. , Maibaum JK , Ostermann N. , Zimmermann J. , Masuya K. , et al: Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity. World Patent WO/2007/006534, January 18, 2007.

20.

Fergus S. , Bender A. , Spring DR : Assessment of structural diversity in combinatorial synthesis. Curr Opin Chem Biol 2005;9:304-309.

21.

Fabbro D. , Ruetz S. , Buchdunger E. , Cowan-Jacob SW , Fendrich G. , Liebetanz J. , et al: Protein kinases as targets for anticancer agents: from inhibitors to useful drugs. Pharmacol Ther 2002;93(2-3):79-98.

22.

Bindseil KU , Jakupovic J. , Wolf D. , Lavayre J. , Leboul J. , van der Pyl D. : Pure compound libraries; a new perspective for natural product based drug discovery. Drug Discov Today 2001;6:840-847.